Beyond the Surface: Unveiling Cardiometabolic Pathophysiology through Advanced Imaging and Biomarker Discovery
My research leverages advanced, non-invasive imaging techniques, particularly MRI and quantitative tissue phenotyping, to uncover hidden myocardial changes and disease mechanisms that are often undetectable through conventional methods. The “Beyond the Surface” project utilizes cutting-edge imaging tools—such as ultrahigh-field 7T human scanners and preclinical 9.4T systems—enabling “virtual biopsies” that detect subtle alterations in cardiac and other tissues. This multidisciplinary approach integrates MRI, AI-enhanced analysis, metabolomics, and advanced optical imaging to decode complex metabolic patterns and mitochondrial health, offering insights into the development and etiology of chronic cardiometabolic diseases.
